Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
J Med Virol
    September 2022
  1. HERMANUSSEN L, Grewe I, Tang HT, Norz D, et al
    Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern - A first case-series experience.
    J Med Virol. 2022 Sep 30. doi: 10.1002/jmv.28181.
    >> Share

  2. SHCHEMELEV AN, Boumbaly S, Ostankova YV, Zueva EB, et al
    Prevalence of drug resistant HIV-1 forms in patients without any history of ART in the Republic of Guinea.
    J Med Virol. 2022 Sep 29. doi: 10.1002/jmv.28184.
    >> Share

  3. SERWIN K, Scheibe K, Horecki M, Aksak-Was B, et al
    Detection of Polish cases of highly virulent subtype B of HIV-1 originating in the Netherlands.
    J Med Virol. 2022 Sep 15. doi: 10.1002/jmv.28154.
    >> Share

    August 2022
  4. GENG Y, Wang Y
    Stability and transmissibility of SARS-CoV-2 in the environment.
    J Med Virol. 2022 Aug 30. doi: 10.1002/jmv.28103.
    >> Share

  5. GHALEKHANI N, Bokaie S, Eybpoosh S, Akbarein H, et al
    Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries.
    J Med Virol. 2022 Aug 24. doi: 10.1002/jmv.28090.
    >> Share

  6. KHELLAF L, Bouscarat F, Burrel S, Fidouh N, et al
    Novel mutations in antiviral multiresistant HSV-2 genital lesion: a case report.
    J Med Virol. 2022 Aug 16. doi: 10.1002/jmv.28070.
    >> Share

  7. JIANG X, Sharma PP, Rathi B, Ji X, et al
    Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein.
    J Med Virol. 2022 Aug 10. doi: 10.1002/jmv.28064.
    >> Share

    July 2022
  8. RUPASINGHE D, Choi JY, Yunihastuti E, Kiertiburanakul S, et al
    Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific.
    J Med Virol. 2022 Jul 22. doi: 10.1002/jmv.28019.
    >> Share

  9. LAN J, Li W, Yu R, Syed F, et al
    Cell-to-cell transmission of HIV-1 from provirus-activated cells to resting naive and memory human primary CD4 T cells is highly efficient and requires CD4 and F-actin but not chemokine receptors.
    J Med Virol. 2022 Jul 15. doi: 10.1002/jmv.28005.
    >> Share

    June 2022
  10. ZHU K, Xu Q, Ma Y, Li P, et al
    Suboptimal Immune Recovery and Associated Factors Among People Living with HIV/AIDS on Second-line Antiretroviral Therapy in Central China: A Retrospective Cohort Study.
    J Med Virol. 2022 Jun 16. doi: 10.1002/jmv.27944.
    >> Share

  11. AGUILAR G, Truong HM, Ovelar P, Samudio T, et al
    HIV Drug Resistance in Persons Initiating or Re-initiating First-line Antiretroviral Therapy in Paraguay: Results of a National Patient Survey.
    J Med Virol. 2022 Jun 14. doi: 10.1002/jmv.27933.
    >> Share

  12. BRAGAZZI NL, Kong JD, Mahroum N, Tsigalou C, et al
    Epidemiological trends and clinical features of the ongoing monkeypox epidemic: a preliminary pooled data analysis and literature review.
    J Med Virol. 2022 Jun 12. doi: 10.1002/jmv.27931.
    >> Share

  13. ASHURO AA, Zhang SC, Wang T, Chu QS, et al
    The Effect of protease inhibitors-based antiretroviral therapy on serum/plasma interleukin-6 levels among PLHIV: a systematic review and meta-analysis.
    J Med Virol. 2022 Jun 6. doi: 10.1002/jmv.27912.
    >> Share

  14. SAIED AA, Nascimento MSL, Rangel AHDN, Skowron K, et al
    Transchromosomic bovines (TcB)-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1 and Influenza A virus.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27907.
    >> Share

    May 2022
  15. BORGHETTI A, Farinacci D, Ciccullo A, Dusina A, et al
    Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice.
    J Med Virol. 2022 May 31. doi: 10.1002/jmv.27890.
    >> Share

  16. FLEISCHER B, Olum R, Nakwagala FN, Nassozi DR, et al
    Higher intensive care unit consultations for COVID-19 patients living with HIV compared to those without HIV coinfection in Uganda.
    J Med Virol. 2022 May 26. doi: 10.1002/jmv.27887.
    >> Share

  17. CHU FL, Li C, Chen L, Dong B, et al
    Respiratory viruses among pediatric inpatients with acute lower respiratory tract infections in Jinan, China, 2016-2019.
    J Med Virol. 2022 May 20. doi: 10.1002/jmv.27875.
    >> Share

  18. CAI S, Liao G, Yu T, Gao Q, et al
    Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV: A cross-sectional study.
    J Med Virol. 2022 May 18. doi: 10.1002/jmv.27872.
    >> Share

  19. MALONGA GA, Dienta S, Traore FT, Maiga Z, et al
    Human Herpesvirus 8 seroprevalence among blood donors in Mali.
    J Med Virol. 2022 May 11. doi: 10.1002/jmv.27850.
    >> Share

  20. LALLOGO TD, Djigma FW, Sorgho PA, Martinson JJ, et al
    KIR2DL5B and HLA DRB1*12 alleles seems to be associated with protection against HIV-1 in serodiscordant couples in Burkina Faso.
    J Med Virol. 2022 May 2. doi: 10.1002/jmv.27821.
    >> Share

    April 2022
  21. LI Y, Wang X, Jin J, Ma Z, et al
    T cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27814.
    >> Share

  22. YU H, Wu H, Subapriya R, Kaur A, et al
    Single-Center Experience on Progressive Multifocal Leukoencephalopathy (PML) cases, neuroimaging relevance, and management at West Virginia University (WVU).
    J Med Virol. 2022 Apr 21. doi: 10.1002/jmv.27804.
    >> Share

  23. ZHUANG K, Zhang Y, Mo P, Deng L, et al
    Plasma proteomic analysis reveals altered protein abundances in HIV-infected patients with or without Non-Hodgkin Lymphoma.
    J Med Virol. 2022 Apr 12. doi: 10.1002/jmv.27775.
    >> Share

  24. MEHRAEEN E, SeyedAlinaghi S, Karimi A
    The Post-Omicron Situation: The End of the Pandemic or a Bigger Challenge?
    J Med Virol. 2022 Apr 6. doi: 10.1002/jmv.27765.
    >> Share

    March 2022
  25. FIORE BD, Andrea V, Giuseppe P, Yagai B, et al
    Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
    J Med Virol. 2022 Mar 31. doi: 10.1002/jmv.27754.
    >> Share

  26. HUANG J, Wu H, Lin S, Lu L, et al
    Spatial-temporal analysis of HIV/AIDS and syphilis in mainland China from 2007 to 2017.
    J Med Virol. 2022 Mar 16. doi: 10.1002/jmv.27725.
    >> Share

  27. WILLIAMS ME, Ruhanya V, Paul RH, Ipser JC, et al
    An investigation of the HIV Tat C31S and R57S mutation on peripheral immune marker levels in South African participants: A pilot study.
    J Med Virol. 2022 Mar 13. doi: 10.1002/jmv.27720.
    >> Share

  28. GIOVANETTI M, Farcomeni S, Sernicola L, Virtuoso S, et al
    Analysis of HIV-1 integrase genotypes and polymorphisms among integrase inhibitors-based antiretroviral treatment naive patients in South Sudan.
    J Med Virol. 2022 Mar 11. doi: 10.1002/jmv.27713.
    >> Share

  29. SU B, Kong D, Yang X, Zhang T, et al
    Mucosal-associated invariant T cells: a cryptic coordinator in HIV-infected immune reconstitution.
    J Med Virol. 2022 Mar 3. doi: 10.1002/jmv.27696.
    >> Share

    February 2022
  30. MARAIS G, Naidoo M, McMullen K, Stanley A, et al
    Varicella-zoster virus reactivation is frequently detected in HIV-infected individuals presenting with stroke.
    J Med Virol. 2022 Feb 8. doi: 10.1002/jmv.27651.
    >> Share

  31. SHAHZAD M, Chen H, Akhtar T, Rafi A, et al
    Human Immunodeficiency Virus: The potential of medicinal plants as anti-retroviral therapy.
    J Med Virol. 2022 Feb 6. doi: 10.1002/jmv.27648.
    >> Share

  32. MILANO E, Ricciardi A, Casciaro R, Pallara E, et al
    Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: a monocentric study in Bari, Italy.
    J Med Virol. 2022 Feb 1. doi: 10.1002/jmv.27629.
    >> Share

    January 2022
  33. COUTLEE F, de Pokomandy A, Burchell AN, El-Zein M, et al
    Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples.
    J Med Virol. 2022 Jan 20. doi: 10.1002/jmv.27605.
    >> Share

  34. ZHANG X, Fang Q, Zhu S, Wu X, et al
    Environmental risk factors and genetic markers of Kaposi's sarcoma-associated herpesvirus infection among Uygur population in Xinjiang, China.
    J Med Virol. 2022 Jan 18. doi: 10.1002/jmv.27600.
    >> Share

  35. LI T, Cui Z, Jia Y, Liang Z, et al
    Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift.
    J Med Virol. 2022 Jan 14. doi: 10.1002/jmv.27596.
    >> Share

  36. KURY CMH, Guimaraes GR, Leandro CG, Fernandes LA, et al
    Associations of human papillomavirus (HPV) genotypes and related risk factors in a cohort of women living with HIV in a Brazilian countryside city.
    J Med Virol. 2022 Jan 9. doi: 10.1002/jmv.27582.
    >> Share

  37. AKEKAWATCHAI C, Phuegsilp C, Changsri K, Soimanee T, et al
    Distribution of +874T/A IFN-gamma and -509C/T TGF-beta1 Single Nucleotide Polymorphisms in Human Immunodeficiency Virus-infected Thais.
    J Med Virol. 2022 Jan 4. doi: 10.1002/jmv.27567.
    >> Share

  38. MOUSAVI SH, Qaderi S, Ahmadi A, Arman SI, et al
    The daunting task of fighting HIV in Afghanistan: Current evidence and future recommendationsThe daunting task of fighting HIV in Afghanistan: Current evidence and future recommendations.
    J Med Virol. 2022 Jan 3. doi: 10.1002/jmv.27566.
    >> Share

  39. ADACHI E, Saito M, Nagai H, Ikeuchi K, et al
    Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV.
    J Med Virol. 2022 Jan 2. doi: 10.1002/jmv.27543.
    >> Share

    December 2021
  40. DENG H, Feng Q, Wu Y, Lin H, et al
    Immune response to hepatitis B vaccination in human immunodeficiency virus-positive patients in China: A 2-year retrospective study.
    J Med Virol. 2021 Dec 14. doi: 10.1002/jmv.27523.
    >> Share

  41. BORSETTI A, Scarpa F, Maruotti A, Divino F, et al
    The unresolved question on COVID-19 virus origin: The three cards game?
    J Med Virol. 2021 Dec 12. doi: 10.1002/jmv.27519.
    >> Share

    October 2021
  42. CHAVAN VR, Ahir S, Kerkar S, Ansari Z, et al
    Th1 cytokine gene polymorphism and the corresponding plasma cytokine levels: A comparative study in HIV-1 positive and exposed uninfected infants.
    J Med Virol. 2021 Oct 26. doi: 10.1002/jmv.27408.
    >> Share

  43. MATSUDA EM, Ahagon CM, Coelho LPO, Campos IB, et al
    A simple algorithm for selecting cases to investigate acute and early HIV infections in low- and middle-income countries.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27398.
    >> Share

  44. RAHMAN S, Sarker MS, Aralaguppe SG, Sarwar G, et al
    Drug resistance pattern among ART-naive clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    J Med Virol. 2021 Oct 12. doi: 10.1002/jmv.27387.
    >> Share

    August 2021
  45. HASAN MM, Mohanan P, Emmanuella N, Costa ACDS, et al
    Challenges of HIV amidst COVID-19 in Africa: Can we conquer them?
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27276.
    >> Share

  46. ZHOU R, Liu L, Wang Y
    Viral Proteins Recognized by Different TLRs.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27265.
    >> Share

  47. COUSIN E, Belicard F, Michel L, Pronier C, et al
    Severe cytomegalovirus disease with encephalitis after CAR-T cell therapy: a rare but potentially fatal complication.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27257.
    >> Share

    July 2021
  48. PEREIRA-VAZ J, Crespo P, Mocho L, Martinho P, et al
    Identification of a new 2-amino acid insertion in the integrase coding region of HIV-1 subtype G isolates.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27205.
    >> Share

    June 2021
  49. ULLAH I, Hassan W, Tahir MJ, Ahmed A, et al
    Antiretrovirals shortage in Kenya amid COVID-19.
    J Med Virol. 2021 Jun 18. doi: 10.1002/jmv.27134.
    >> Share

  50. SILVA DMD, Goncales JP, Silva Junior JVJ, Lopes TRR, et al
    Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-alpha, and IFN-gamma cytokines in HIV/HHV-8 coinfection.
    J Med Virol. 2021;93:4033-4037.
    >> Share

  51. LU J, Jia J, Zhang J, Liu X, et al
    HIV p17 enhances T cell proliferation by suppressing autophagy through the p17-OLA1-GSK3beta axis under nutrient starvation.
    J Med Virol. 2021;93:3607-3620.
    >> Share

  52. DAI L, Jung BG, Chen J, Samten B, et al
    The potential impacts of early secreted antigenic target of 6 kDa of Mycobacterium tuberculosis on KSHV-infected cells.
    J Med Virol. 2021;93:4028-4032.
    >> Share

  53. DA SILVA PRATES G, Malta FM, de Toledo Goncalves F, Monteiro MA, et al
    AIDS incidence and survival in a hospital-based cohort of HIV-positive patients from Sao Paulo, Brazil: The role of IFN-lambda4 polymorphisms.
    J Med Virol. 2021;93:3601-3606.
    >> Share

    May 2021
  54. TING Y, Liang S, Yang S, Lin Y, et al
    Phylogenetic characteristics of HIV among female cross-border travelers in Yunnan Province between 2003 and 2012.
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27079.
    >> Share

    April 2021
  55. SANTINELLI L, De Girolamo G, Borrazzo C, Vassalini P, et al
    Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27028.
    >> Share

  56. PATEL UK, Malik P, Li Y, Habib A, et al
    Stroke and HIV-Associated Neurological Complications: A Retrospective Nationwide Study.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27010.
    >> Share

  57. BULFONI M, Pravisani R, Dalla E, Cesselli D, et al
    miRNA expression profiles in liver grafts of HCV and HIV/HCV infected recipients, six months after liver transplantation.
    J Med Virol. 2021 Apr 5. doi: 10.1002/jmv.26999.
    >> Share

    March 2021
  58. ARRAIS CRA, Lima K, Barreiros M, Rodrigues JKF, et al
    HIV-1 Subtypes and Drug Resistance in Children During Antiretroviral Therapy in Brazil.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26988.
    >> Share

  59. WU Y, Yang Y, Wei H, Jia L, et al
    Mortality Predictors among Patients with HIV-Associated Pulmonary Tuberculosis in Northeast China: A Retrospective Cohort Analysis.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26977.
    >> Share

    February 2021
  60. OLUSOLA BA, Olaleye DO, Odaibo GN
    New Infections and HIV-1 Subtypes Among Febrile Persons and Blood Donors in Oyo State, Nigeria.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26872.
    >> Share

  61. ROJAS-BOLIVAR D, Intimayta-Escalante C, Cardenas-Jara A, Jandarov R, et al
    COVID-19 case fatality rate and tuberculosis in a metropolitan setting.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26868.
    >> Share

    January 2021
  62. NASREDDINE R, Florence E, Moutschen M, Yombi JC, et al
    Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26828.
    >> Share

  63. O'ROURKE S, O'Flaherty N, Coyne D, Lynam A, et al
    Seroprevalence of human herpesvirus 8 in Ireland among blood donors, men who have sex with men and heterosexual Genitourinary Medicine and Infectious Diseases clinic attendees.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26813.
    >> Share

  64. HUANG XH, Yu G, Zheng C, Zhou PP, et al
    Genomic characterization of a new CRF01_AE/CRF07_BC case from a MSM patient in Guangdong, China.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26799.
    >> Share

    December 2020
  65. DUBEY RC, Alam NB, Gaur R
    miR-150-mediated increase in glucose uptake in HIV-infected cells.
    J Med Virol. 2020 Dec 24. doi: 10.1002/jmv.26755.
    >> Share

  66. SARKAR S, Khanna P, Singh AK
    Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26740.
    >> Share

  67. ANNAMALAY AA, Abbott S, Khoo SK, Hibbert J, et al
    The Impact of Cytokine Levels in Young South African Children with and without HIV-associated Acute Lower Respiratory Infections.
    J Med Virol. 2020 Dec 14. doi: 10.1002/jmv.26730.
    >> Share

  68. LATHOUWERS E, Weinsteiger S, Baugh B, Ghys A, et al
    Week 96 resistance analyses of the once-daily, Single-tablet Regimen (STR) Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26721.
    >> Share

  69. WAN T, Liu X, Su Y, Zou J, et al
    Biological Differentiation of Traditional Chinese Medicine from Excessive to Deficient Syndromes in AIDS: Comparative MicroRNA Microarray Profiling and Syndrome-Specific Biomarker Identification.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26704.
    >> Share

    November 2020
  70. SWAMINATHAN N, Moussa P, Mody N, Bryan Lo K, et al
    COVID-19 in HIV infected patients: A Case series and Literature Review.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26671.
    >> Share

  71. ZENG J, Zhang X, Jia L, Wu Y, et al
    Pretreatment Lymphocyte-to-Monocyte Ratios Predict AIDS-related Diffuse Large B-Cell Lymphoma Overall Survival.
    J Med Virol. 2020 Nov 6. doi: 10.1002/jmv.26655.
    >> Share

    October 2020
  72. TEKIN D, Gokengin D, Onay H, Erensoy S, et al
    Investigation of Drug Resistance Against Protease, Reverse Transcriptase and Integrase Inhibitors by Next Generation Sequencing in HIV Positive Patients.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26582.
    >> Share

  73. CAKIR B
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 2. doi: 10.1002/jmv.26576.
    >> Share

    September 2020
  74. LY HI, Kelly M, Fall MVM, Fall-Malick FZ, et al
    Prevalence of therapeutic failure and evolution of biological factors amongst people living with HIV enrolled in anti-retroviral therapy at the Ambulatory Treatment Center in Nouakchott, Mauritania.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26562.
    >> Share

  75. MONDI A, Cimini E, Colavita F, Cicalini S, et al
    COVID-19 in people living with HIV: clinical implications of dynamics of immune response to SARS-CoV-2.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26556.
    >> Share

  76. NAGARAKANTI SR, Okoh AK, Grinberg S, Bishburg E, et al
    Clinical outcomes of patients with COVID-19 and HIV coinfection.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26533.
    >> Share

    August 2020
  77. PATRA R, Chandra Das N, Mukherjee S
    Targeting human TLRs to combat COVID-19: A solution?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26387.
    >> Share

    July 2020
  78. RAMASWAMY M, Bruden D, Nolen LD, Mosites E, et al
    Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26327.
    >> Share

  79. PRZYDZIAL P, Tchomobe G, Amin K, Christian E, et al
    When COVID-19 Crosses Paths with AIDS in the Homeless.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26255.
    >> Share

    April 2020
  80. CURE E, Cumhur Cure M
    Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19".
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25848.
    >> Share

    March 2020
  81. OH JJ, Carter JJ, Nemeno JGE, Dix RD, et al
    Parthanatos-associated proteins are stimulated intraocularly during development of experimental murine cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression.
    J Med Virol. 2020;92:394-398.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016